UT Southwestern’s grants have come from the National Science Foundation (NSF) and the National Institutes of Health (NIH), which was allotted $10 billion to distribute through the Recovery Act. Additional grant applications from UT Southwestern are still pending.
The $42 million represents both direct costs – funds that go directly to the researcher – and indirect costs, which go to UT Southwestern to support institutional infrastructure. The total amount reflects funds received in fiscal 2009; many grants allow a two-year period to spend the funds.
As of early October, UT Southwestern faculty are principal investigators on 105 Recovery Act projects (104 through NIH, one through NSF), and two investigators had received Recovery Act funds by virtue of being subcontractors on grants awarded to other institutions. Dr. Perrie Adams, associate dean for research administration at UT Southwestern, said more grants probably will be awarded in the coming weeks and months.
“Even though the funding period for most of these grants is only two years, the hope is that their results ultimately will contribute significantly to patient care, in terms of new treatments or a better understanding of specific diseases,” Dr. Adams said. “This funding also allows investigators to gather data that will then allow them to pursue larger, longer-term grants. In addition, for some of our young investigators, getting their ideas funded at this level starts them on the path toward establishing themselves. It’s a major asset for leveraging in order to obtain future funding.”
The research grants support a wide range of laboratory and patient-centered studies aimed at improving the nation’s health, including projects focusing on cancer, heart disease, kidney disease, autism, neurodegenerative diseases and diabetes.
Some examples illustrate the anticipated impact of the grants:
• Dr. Joseph Hill, chief of cardiology, “Functional Genomics of Complex Vascular Disease,” $1,287,252. This grant will help expand research on the mechanisms of cardiovascular disease and includes support for a new, early-career faculty member. “More than 200 genetic associations with cardiovascular disease have been identified. Moving forward, we need to know how this information can be harnessed to predict who will develop heart disease and possibly develop new ways to intervene early in at-risk patients,” Dr. Hill said.
• Dr. Craig Powell, assistant professor of neurology and psychiatry, “Novel Genetic Animal Models of Autism,” $549,500. The goal of this project is to understand better the genetic causes of human autism by using genetically engineered animal models of the disease. “This approach can be used to identify novel therapies for patients with autism,” Dr. Powell said.
• Dr. Elizabeth Maher, associate professor of internal medicine and neurology, “Genotype and Metabolic Phenotype in Glioblastoma,” $1 million. Glioblastoma is the most common primary brain tumor and is considered one of the deadliest of human cancers. Dr. Maher and her colleagues in the Annette G. Strauss Center in Neuro-Oncology and in the Advanced Imaging Research Center focus on the metabolism of glioblastoma cells as a potential new target. “Our research will dissect the metabolic pathways that are abnormal in glioblastoma in a concerted effort to develop new therapies quickly,” Dr. Maher said. “We anticipate that our discoveries will be applicable to other cancers as well.”
Some of the Recovery Act grants awarded to UT Southwestern and other institutions fall under special priority categories designated by the NIH.
Grand Opportunities grants
Two UT Southwestern researchers received NIH Grand Opportunities grants, which support high-impact ideas that lend themselves to short-term funding and that might lay the foundation for new fields of investigation. Dr. Ellen Vitetta, director of the Cancer Immunobiology Center, was awarded $1,303,720 for research to develop a new vaccine for the hepatitis C virus, a major cause of liver cancer. Dr. Michael Roth, professor of biochemistry, received $3.75 million for a project that ultimately will produce a large database that researchers can use to design patient-specific, individualized therapies for lung cancer.
Ten of UT Southwestern’s Recovery Act grants are NIH Challenge Grants in Health and Science Research, a new initiative that focuses on specific knowledge gaps, scientific opportunities, new technologies, data generation or research methods that can benefit from an influx of funds to quickly advance disease-specific areas in significant ways. Dr. Maher’s grant falls into this category.Summer research experience for teachers and students
Dr. Perrie Adams -- www.utsouthwestern.edu/findfac/professional/0,2356,10035,00.html
Amanda Siegfried | Newswise Science News
CRTD receives 1.56 Mill. Euro BMBF-funding for retinal disease research
24.05.2017 | DFG-Forschungszentrum für Regenerative Therapien TU Dresden
BMBF funds translational project to improve radiotherapy
10.05.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
26.05.2017 | Life Sciences
26.05.2017 | Life Sciences
26.05.2017 | Physics and Astronomy